Adam Heisinger, DO
Orthopaedic Surgery · Tigard, ORNPI 1144460296
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,659 of the $9,946 with a category attached, or 67.0%. 18 manufacturers reported payments, led by Arthrex at 30.3% of the total. Reporting peaked in 2023 at $4,704 and has fallen 92.4% since, to $356 in 2025.
Across 91 payments — averaging $109.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Summit Surgical Corp.$3K
- Smith+Nephew$2K
- Restor3d, Inc.$198
- Johnson & Johnson$186
- Miach Orthopaedics, Inc.$149
- plus $946 from 12 others
What the payments were for
- Travel & lodging$6,65967%
- Food & beverage$3,28633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 40 | $3,018 |
| Summit Surgical Corp. | 6 | $2,998 |
| Smith+Nephew | 20 | $2,451 |
| Restor3d, Inc. | 2 | $198 |
| Johnson & Johnson | 3 | $186 |
| Miach Orthopaedics, Inc. | 1 | $149 |
| Vericel Corporation | 2 | $139 |
| Pacira Pharmaceuticals Incorporated | 2 | $138 |
| Left Coast Surgical Inc | 2 | $137 |
| Stryker | 2 | $134 |
| Globus Medical | 2 | $122 |
| Bioventus LLC | 2 | $61 |
| Steelhead Surgical Inc | 2 | $54 |
| Omnilife Science, Inc | 1 | $40 |
| Linvatec Corporation | 1 | $40 |
| Fortis Surgical, LLC | 1 | $34 |
| Fidia Pharma USA Inc. | 1 | $29 |
| Vertex | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTRABUTTON$1,356
- Bone Anchors with Arthroscopic Delivery System$705
- MICRORAPTOR$651
- Q-FIX$651
- REDAPT$575
- Coblation$130
- MACI$125
- EXPAREL$122
- REAL INTELLIGENCE$120
- SPATIAL FRAME$118
- Healicoil$118
How this compares
$9,946 in reported general payments places this provider in the 75th percentile of 228 orthopaedic surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 33 | $557 |
| Celecoxib | 44 | $505 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $504 |
| Oxycodone Hcl | 21 | $197 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tigard
- Christopher NansonTigard$73K
- Brian PuskasTigard$11K
- Mark WagnerTigard$10K
- Patrick DenardMedford$11.5M
- James BallardOregon City$2.4M
- Steven MadeyLake Oswego$1.2M
- Daniel FitzpatrickEugene$481K
- Michelle WelbornPortland$364K
- Elizabeth LiebermanPortland$353K
- Jonathan SalesPortland$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.